A new analysis suggests that the Omicron variant has comparable intrinsic severity to the ancestral (Wuhan) SARS-CoV-2 strain, but its effective severity is substantially lower because of vaccination.
...
Case-patients with at least one dose of Pfizer-BioNTech or CoronaVac vaccine had significantly lower odds of mortality than unvaccinated patients, the authors said, with the lowest odds observed in people who had received three Pfizer doses (odds ratio, 0.31; 95% CI, 0.18 to 0.49).
Though COVID-19 cases and deaths continued to decline over the past 4 weeks, the World Health Organization (WHO) is tracking rises in two of its regions, South East Asia and the Eastern Mediterranean. In its weekly update today, it also noted rises in individual countries in other parts of the world.
Some nations could be paying ten times the price of Paxlovid’s generic equivalent, as WHO chief calls for treatment access to battle acute and long COVID-19
Rich countries have secured almost three times as many courses of a World Health Organisation (WHO)-recommended COVID-19 medicine, Pfizer’s Paxlovid, according to new analysis from Oxfam and the People’s Vaccine Alliance.